Pierre Weiss

Prof. Pierre Weiss

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
GDGuy Daculsi
Guy Daculsi
OLOlivier Laboux
Olivier Laboux
OMOlivier Malard
Olivier Malard
PWPierre Weiss
Pierre Weiss

1 May 2008 in Acta Biomaterialia
Verified
Journal Article
Closed access
LGLaurent Le Guehennec
Laurent Le Guehennec
MLMarco-Antonio Lopez-Heredia
Marco-Antonio Lopez-Heredia
BEBenedicte Enkel
Benedicte Enkel
PWPierre Weiss
Pierre Weiss
YAYves Amouriq
Yves Amouriq
Pierre LayrollePierre Layrolle
Pierre Layrolle

1 April 2011 in Biomaterials
Verified
Journal Article
Closed access
ECEstelle C. Collin
Estelle C. Collin
SGSibylle Grad
Sibylle Grad
Dimitrios ZeugolisDimitrios Zeugolis
Dimitrios Zeugolis
CVClaire S. Vinatier
Claire S. Vinatier
JCJohann R. Clouet
Johann R. Clouet
Abhay PanditAbhay Pandit
Abhay Pandit

1 December 2009 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
CVClaire Vinatier
Claire Vinatier
CBCarine Bouffi
Carine Bouffi
CMChristophe Merceron
Christophe Merceron
JGJan Gordeladze
Jan Gordeladze
JBJean‐Marc Brondello
Jean‐Marc Brondello
Daniele NoelDaniele Noel
Daniele Noel
Injuries to articular cartilage are one of the most challenging issues of musculoskeletal medicine due to the poor intrinsic ability of this tissue for repair. Despite progress in orthopaedic surgery, the lack of efficient modalities of treatment for large chondral defects has prompted research on tissue engineering combining chondrogenic cells, scaffold materials and environmental factors. The aim of this review is to focus on the recent advances made in exploiting the potentials of cell therapy for cartilage engineering. These include: 1) defining the best cell candidates between chondrocytes or multipotent progenitor cells, such as multipotent mesenchymal stromal cells (MSC), in terms of readily available sources for isolation, expansion and repair potential; 2) engineering biocompatible and biodegradable natural or artificial matrix scaffolds as cell carriers, chondrogenic factors releasing factories and supports for defect filling, 3) identifying more specific growth factors and the appropriate scheme of application that will promote both chondrogenic differentiation and then maintain the differentiated phenotype overtime and 4) evaluating the optimal combinations that will answer to the functional demand placed upon cartilage tissue replacement in animal models and in clinics. Finally, some of the major obstacles generally encountered in cartilage engineering are discussed as well as future trends to overcome these limiting issues for clinical applications.

17 May 2022 in Progress in Materials Science
Verified
Journal Article
Closed access
MGMarie-Michèle Germaini
Marie-Michèle Germaini
SBSofiane Belhabib
Sofiane Belhabib
SGSofiane Guessasma
Sofiane Guessasma
RDRémi Deterre
Rémi Deterre
PCPierre Corre
Pierre Corre
PWPierre Weiss
Pierre Weiss

1 March 2008 in Biomaterials
Verified
Journal Article
Closed access
BFBorhane H. Fellah
Borhane H. Fellah
OGOlivier Gauthier
Olivier Gauthier
PWPierre Weiss
Pierre Weiss
DCDaniel Chappard
Daniel Chappard
Pierre LayrollePierre Layrolle
Pierre Layrolle